IPO Price History
Closed
Sotac Pharmaceuticals Limited logo

Sotac Pharmaceuticals Limited IPO

SME IPOListedSOTACNSE
Current Market Price (CMP)
₹154.05(+38.78%)
Current Price (CMP)
₹154.05(+38.78%)

Live Market Quote

Listing Price & Gain
₹115(+3.60%)

Day 1 Exchange Open

IPO Issue Price
₹111

Band: ₹105 - ₹111

Total Subscription
1.49x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
29 Mar 2023
IPO Bidding Closes
03 Apr 2023
Allotment & Refunds
Completed
Exchange Listing Day
13 Apr 2023

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 1.49x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)0x
Non-Institutional Investors (NII / HNI)0x
Retail Individual Investors (RII)0x
Total Subscription1.49x
Updated as on 03-Apr-2023 18:15:00

Listing Day & Return Performance

Listing Day Gain+3.60%
₹111 (Issue) → ₹115 (List)
Per share profit: +₹4.00
Holding Return (Till Date)+38.78%
₹111 (Issue) → ₹154.05 (CMP)
Net gain per share: +₹43.05
Post-Listing Performance (Listing Day → Today):+33.96%

About Sotac Pharmaceuticals Limited IPO

Sotac Pharmaceuticals Limited is an Indian public offering categorized under the SME (Small and Medium Enterprise) segment. The public issue opened for bidding on 29 Mar 2023 and concluded on 03 Apr 2023, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹105 - ₹111.

During the bidding window, Sotac Pharmaceuticals Limited recorded an overall subscription of 1.49 times. Institutional investors (QIB) subscribed —, non-institutional high-net-worth investors (NII) subscribed —, and retail individual investors (RII) bid — their reserved quota.

The equity shares of Sotac Pharmaceuticals Limited officially debuted on the stock exchanges on 13 Apr 2023 at an opening listing price of ₹115, delivering a listing day return of +3.60% (premium) over the final issue price. As per the latest market data, the stock trades at ₹154.05, representing an overall gain of +38.78% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Sotac Pharmaceuticals Limited IPO?
The issue price of Sotac Pharmaceuticals Limited IPO was fixed at ₹111 per equity share. The indicative bidding price band was ₹105 - ₹111.
What were the open, close, and listing dates for Sotac Pharmaceuticals Limited IPO?
Sotac Pharmaceuticals Limited IPO opened on 29 Mar 2023, closed on 03 Apr 2023, listed on 13 Apr 2023.
How much was Sotac Pharmaceuticals Limited IPO subscribed?
The IPO received an overall subscription of 1.49 times. Category-wise, QIBs subscribed —x, NIIs subscribed —x, and Retail investors subscribed —x.
What was the listing price and listing gain of Sotac Pharmaceuticals Limited IPO?
Sotac Pharmaceuticals Limited IPO listed on the stock exchange at ₹115, delivering a listing gain of 3.60% compared to the IPO issue price of ₹111.
Is Sotac Pharmaceuticals Limited IPO a Mainboard or SME IPO?
Sotac Pharmaceuticals Limited IPO is a SME IPO listed on the SME platform of NSE.
What is the current return of Sotac Pharmaceuticals Limited IPO since its IPO?
At the latest market quote of ₹154.05, Sotac Pharmaceuticals Limited IPO has generated an all-time return of +38.78% since its initial public offering.

Related SME IPOs (2023)

TECHLABS
Trident Techlabs Limited
₹35+180.43%
INDIFRA
Indifra Limited
₹65+10.77%
SUPREMEPWR
Supreme Power Equipment Limited
₹65+50.77%
EFORCE
Electro Force (India) Limited
₹93+7.53%